GlaxoSmithKline Newsroom

Express News | The well-known European activist investment firm Bluebell is shutting down its hedge fund.

BreakingsDec 16 21:46

The Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Expanding The Approval Of GSK's Jemperli (Dostarlimab) In Combination With Chemotherapy (Carboplatin And Paclitaxel) For First-line Treatment For...

BenzingaDec 16 18:04

GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK

Proactive InvestorsDec 16 16:18

GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA

MT NewswiresDec 16 15:42

GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

WSJDec 16 15:37

ViiV Healthcare Announces CHMP Positive Opinion for Vocabria + Rekambys, the First and Only Complete Long-acting HIV Treatment, for Adolescents in Europe

GSK PlcDec 16 13:00

GSK's B7-H3-targeted Antibody-drug Conjugate, GSK'227, Receives EMA Priority Medicines (PRIME) Designation in Relapsed Extensive-stage Small-cell Lung Cancer

GSK PlcDec 16 13:00

Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer

GSK PlcDec 16 13:00

Jemperli (Dostarlimab) Receives US FDA Breakthrough Therapy Designation for Locally Advanced DMMR/MSI-H Rectal Cancer

GSK PlcDec 16 13:00

Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children

BenzingaDec 14 04:57

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis

BenzingaDec 14 00:06

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

BenzingaDec 13 02:13

Barclays Remains a Hold on GlaxoSmithKline (GSK)

TipRanksDec 12 15:35 · Ratings

Anaptys Scraps Development of ANB032, Stock Plunges 33%

Seeking AlphaDec 12 00:52

TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45

Futu NewsDec 11 23:32 · Ratings

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

Zacks Dec 11 22:30

Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksDec 11 20:35 · Ratings

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex

BenzingaDec 11 02:14

India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma

Yahoo FinanceDec 10 20:25

GSK, Relation Therapeutics Partner to Advance Osteoarthritis, Fibrotic Disease Treatments

WSJDec 10 16:24